- Home
- VTVT vs APYX Comparison
VTVT vs APYX Comparison
Compare VTVT & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTVT
- APYX
- Stock Information
- Founded
- VTVT 2015
- APYX 1982
- Country
- VTVT United States
- APYX United States
- Employees
- VTVT N/A
- APYX N/A
- Industry
- VTVT Biotechnology: Pharmaceutical Preparations
- APYX Medical/Dental Instruments
- Sector
- VTVT Health Care
- APYX Health Care
- Exchange
- VTVT Nasdaq
- APYX Nasdaq
- Market Cap
- VTVT 56.7M
- APYX 66.5M
- IPO Year
- VTVT 2015
- APYX 1987
- Fundamental
- Price
- VTVT $14.49
- APYX $2.16
- Analyst Decision
- VTVT Strong Buy
- APYX Hold
- Analyst Count
- VTVT 2
- APYX 2
- Target Price
- VTVT $35.50
- APYX N/A
- AVG Volume (30 Days)
- VTVT 7.9K
- APYX 72.0K
- Earning Date
- VTVT 08-07-2025
- APYX 08-07-2025
- Dividend Yield
- VTVT N/A
- APYX N/A
- EPS Growth
- VTVT N/A
- APYX N/A
- EPS
- VTVT N/A
- APYX N/A
- Revenue
- VTVT $17,000.00
- APYX $47,288,000.00
- Revenue This Year
- VTVT N/A
- APYX $2.25
- Revenue Next Year
- VTVT N/A
- APYX $6.76
- P/E Ratio
- VTVT N/A
- APYX N/A
- Revenue Growth
- VTVT N/A
- APYX N/A
- 52 Week Low
- VTVT $12.12
- APYX $0.76
- 52 Week High
- VTVT $26.99
- APYX $2.30
- Technical
- Relative Strength Index (RSI)
- VTVT 35.02
- APYX 61.66
- Support Level
- VTVT $15.18
- APYX $1.84
- Resistance Level
- VTVT $16.76
- APYX $2.29
- Average True Range (ATR)
- VTVT 0.59
- APYX 0.22
- MACD
- VTVT 0.04
- APYX 0.03
- Stochastic Oscillator
- VTVT 0.00
- APYX 80.28
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.